Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
José Nativi-Nicolau(Jacksonville College), D. Eric Steidley(WinnMed), H. Moelgaard(Karolinska University Hospital), Jocelyn Inamo(Centre Hospitalier Universitaire de Martinique), Sanjiv J. Shah(Northwestern University), Olga Azevedo(British Heart Foundation), Eun‐Seok Jeon, Nowell M. Fine(University of Calgary), Ronald Witteles(Alnylam Pharmaceuticals (United States)), Claudio Rapezzi(University of Ferrara), Dianna Quan(University of Michigan), Giuseppe Vita(University of Messina), Jonas Wixner(Umeå University), Hans Nienhuis(University Medical Center Groningen), Hartmut Schmidt(Université Paris-Sud), Márcia Waddington‐Cruz(Université Paris-Sud), Burkhard Gess(RWTH Aachen University), José González‐Costello(British Heart Foundation), Michele Emdin(Scuola Superiore Sant'Anna), Marco Luigetti(Università Cattolica del Sacro Cuore), Johan Van Cleemput, Nitasha Sarswat(NorthShore University HealthSystem), Jin Luo(Chengdu Second People's Hospital), Doug Chapman(Pfizer (United States)), Yoshiki Sekijima(Shinshu University), Violaine Planté‐Bordeneuve(Université Paris-Est Créteil), Samantha LoRusso(Ohio University), Fábio Barroso(Université Paris-Sud), Mathew S. Maurer(Alnylam Pharmaceuticals (United States)), Jeffrey Ralph, Pablo García‐Pavía(Universidad Francisco de Vitoria), Arnt V. Kristen(Heidelberg University), Brian Drachman(Penn Presbyterian Medical Center), William Cotts, Stephen S. Gottlieb(University of Maryland, Baltimore), Martha Grogan(Mayo Clinic in Arizona), Tessa Marburger, Olivier Lairez(Hôpital Rangueil), Leslie Amass(Pfizer (United States)), Michael Polydefkis(Université Paris-Sud), Josep Maria Campistol Plana(Hospital Clínic de Barcelona), Calogero Lino Cirami(Azienda Ospedaliero-Universitaria Careggi), David Adams(Mount Sinai Health System), Taro Yamashita(Kanazawa University), Juan González Moreno, Srinivas Murali(Allegheny General Hospital), Alfonso Siu(University of Utah), Angela Dispenzieri(Mayo Clinic), Yeşim Parman(Université Paris-Sud), Maria Alejandra Gonzalez Duarte Briseno(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
Cited by 61
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2018|2.8k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k